Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Žan Toplak, Louise A. Hendrickx, Reham Abdelaziz, Xiaoyi Shi, Steve Peigneur, Tihomir Tomašič, Jan Tytgat, Lucija Peterlin‐Mašič, Luis A. Pardo

Journal title: Medicinal Research Reviews

Journal publisher: John Wiley & Sons Inc.

Published year: 2021

DOI identifier: 10.1002/med.21808

ISSN: 0198-6325